Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Lothstein, L; Israel, M; Sweatman, TW
   Anthracycline drug targeting: cytoplasmic versus nuclear - a fork in the road
   DRUG RESISTANCE UPDATES
   
   L. Lothstein et al., "Anthracycline drug targeting: cytoplasmic versus nuclear - a fork in the road", DRUG RESIST, 4(3), 2001, pp. 169-177
2. Porea, TJ; Dreyer, ZE; Bricker, JT; Mahoney, DH
   Evaluation of left ventricular function in asymptomatic children about to undergo anthracycline-based chemotherapy for acute leukemia: An outcome study
   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
   
   T.J. Porea et al., "Evaluation of left ventricular function in asymptomatic children about to undergo anthracycline-based chemotherapy for acute leukemia: An outcome study", J PED H ONC, 23(7), 2001, pp. 420-423
3. Kramer, K; Kinter, L; Brockway, BP; Voss, HP; Remie, R; Van Zutphen, BLM
   The use of radiotelemetry in small laboratory animals: Recent advances
   CONTEMPORARY TOPICS IN LABORATORY ANIMAL SCIENCE
   
   K. Kramer et al., "The use of radiotelemetry in small laboratory animals: Recent advances", CONT T LAB, 40(1), 2001, pp. 8-16
4. Hershberger, RE; Ni, HY; Toy, W; Wilson, RA
   Distribution and declines in cardiac allograft radionuclide left ventricular ejection fractions in relation to late mortality
   JOURNAL OF HEART AND LUNG TRANSPLANTATION
   
   R.E. Hershberger et al., "Distribution and declines in cardiac allograft radionuclide left ventricular ejection fractions in relation to late mortality", J HEART LUN, 20(4), 2001, pp. 417-424
5. Sayed-Ahmed, MM; Salman, TM; Gaballah, HE; El-Naga, SAA; Nicolai, R; Calvani, M
   Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy
   PHARMACOLOGICAL RESEARCH
   
   M.M. Sayed-Ahmed et al., "Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy", PHARMAC RES, 43(6), 2001, pp. 513-520
6. Wersinger, C; Lelong-Rebel, IH; Rebel, G
   Sensitivity of taurine uptake to oxygen-derived reactive substances in MDRand non-MDR cells
   AMINO ACIDS
   
   C. Wersinger et al., "Sensitivity of taurine uptake to oxygen-derived reactive substances in MDRand non-MDR cells", AMINO ACIDS, 21(2), 2001, pp. 91-117
7. Dazzi, H; Kaufmann, K; Follath, F
   Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia- Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity inpatients treated for acute leukaemia at theUniversity Hospital of Zurich, Switzerland, between 1990 and 1996
   ANNALS OF ONCOLOGY
   
   H. Dazzi et al., "Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia- Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity inpatients treated for acute leukaemia at theUniversity Hospital of Zurich, Switzerland, between 1990 and 1996", ANN ONCOL, 12(7), 2001, pp. 963-966
8. Sato, T; Harada, K; Tamura, M; Watanabe, A; Ishii, M; Takada, G
   Cardiorespiratory exercise capacity and its relation to a new Doppler index in children previously treated with anthracycline
   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
   
   T. Sato et al., "Cardiorespiratory exercise capacity and its relation to a new Doppler index in children previously treated with anthracycline", J AM S ECHO, 14(4), 2001, pp. 256-263
9. Mondelli, JA; Di Luzio, S; Nagaraj, A; Kane, BJ; Smulevitz, B; Nagaraj, AV; Greene, R; McPherson, DD; Rigolin, VH
   The validation of volumetric real-time 3-dimensional echocardiography for the determination of left ventricular function
   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
   
   J.A. Mondelli et al., "The validation of volumetric real-time 3-dimensional echocardiography for the determination of left ventricular function", J AM S ECHO, 14(10), 2001, pp. 994-1000
10. Meinardi, MT; van Veldhuisen, DJ; Gietema, JA; Dolsma, WV; Boomsma, F; van den Berg, MP; Volkers, C; Haaksma, J; de Vries, EGE; Sleijfer, DT; van der Graaf, WTA
    Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients
    JOURNAL OF CLINICAL ONCOLOGY
    
    M.T. Meinardi et al., "Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients", J CL ONCOL, 19(10), 2001, pp. 2746-2753
11. Della Torre, P; Podesta, A; Imondi, AR; Moneta, D; Sammartini, U; Arrigoni, C; Terron, A; Brughera, M
    PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    P. Della Torre et al., "PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential", CANC CHEMOT, 47(4), 2001, pp. 355-360
12. Lopaczynski, W; Zeisel, SH
    Antioxidants, programmed cell death, and cancer
    NUTRITION RESEARCH
    
    W. Lopaczynski e S.H. Zeisel, "Antioxidants, programmed cell death, and cancer", NUTR RES, 21(1-2), 2001, pp. 295-307
13. Hall, KS; Wiklund, T; Erikstein, B; Holte, H; Kvalheim, G; Sommer, HH; Andersen, A; Skovlund, E; Bergh, J; Hall, C
    Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients
    BREAST CANCER RESEARCH AND TREATMENT
    
    K.S. Hall et al., "Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients", BREAST CANC, 67(3), 2001, pp. 235-244
14. Nousiainen, T; Vanninen, E; Jantunen, E; Remes, J; Kuikka, J; Hartikainen, J
    Anthracycline-induced cardiomyopathy: long-term effects on myocardial cellintegrity, cardiac adrenergic innervation and fatty acid uptake
    CLINICAL PHYSIOLOGY
    
    T. Nousiainen et al., "Anthracycline-induced cardiomyopathy: long-term effects on myocardial cellintegrity, cardiac adrenergic innervation and fatty acid uptake", CLIN PHYSL, 21(1), 2001, pp. 123-128
15. Mladosievicova, B; Foltinova, A; Petrasova, H; Bernadic, M; Hulin, I
    Signal-averaged electrocardiography in survivors of Hodgkin's disease treated with and without dexrazoxane
    NEOPLASMA
    
    B. Mladosievicova et al., "Signal-averaged electrocardiography in survivors of Hodgkin's disease treated with and without dexrazoxane", NEOPLASMA, 48(1), 2001, pp. 61-65
16. Mijares, A; Lopez, JR
    L-carnitine prevents increase in diastolic [Ca2+] induced by doxorubicin in cardiac cells
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    A. Mijares e J.R. Lopez, "L-carnitine prevents increase in diastolic [Ca2+] induced by doxorubicin in cardiac cells", EUR J PHARM, 425(2), 2001, pp. 117-120
17. Minotti, G; Parlani, M; Salvatorelli, E; Menna, P; Cipollone, A; Animati, F; Maggi, CA; Manzini, S
    Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogue
    BRITISH JOURNAL OF PHARMACOLOGY
    
    G. Minotti et al., "Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogue", BR J PHARM, 134(6), 2001, pp. 1271-1278
18. Horenstein, MS; Vander Heide, RS; L'Ecuyer, TJ
    Molecular basis of anthracycline-induced cardiotoxicity and its prevention
    MOLECULAR GENETICS AND METABOLISM
    
    M.S. Horenstein et al., "Molecular basis of anthracycline-induced cardiotoxicity and its prevention", MOL GEN MET, 71(1-2), 2000, pp. 436-444
19. Prestor, VV; Rakovec, P; Kozelj, M; Jereb, B
    Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood
    PEDIATRIC HEMATOLOGY AND ONCOLOGY
    
    V.V. Prestor et al., "Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood", PED HEM ONC, 17(7), 2000, pp. 527-540
20. Green, DM; Grigoriev, YA; Nan, B; Takashima, JR; Norkool, PA; D'Angio, GJ; Breslow, NE
    Congestive heart failure after treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group
    JOURNAL OF CLINICAL ONCOLOGY
    
    D.M. Green et al., "Congestive heart failure after treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group", J CL ONCOL, 19(7), 2000, pp. 1926-1934
21. Lackner, H; Benesch, M; Schagerl, S; Kerbl, R; Schwinger, W; Urban, C
    Prospective evaluation of late effects after childhood cancer therapy witha follow-up over 9 years
    EUROPEAN JOURNAL OF PEDIATRICS
    
    H. Lackner et al., "Prospective evaluation of late effects after childhood cancer therapy witha follow-up over 9 years", EUR J PED, 159(10), 2000, pp. 750-758
22. Singal, P; Li, TM; Kumar, D; Danelisen, I; Iliskovic, N
    Adriamycin-induced heart failure: mechanisms and modulation
    MOLECULAR AND CELLULAR BIOCHEMISTRY
    
    P. Singal et al., "Adriamycin-induced heart failure: mechanisms and modulation", MOL C BIOCH, 207(1-2), 2000, pp. 77-86
23. Rammeloo, LAJ; Postma, A; Sobotka-Plojhar, MA; Bink-Boelkens, MTE; van der Does-van der Berg, A; Veerman, AJP; Kamps, WA
    Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: No long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group
    MEDICAL AND PEDIATRIC ONCOLOGY
    
    L.A.J. Rammeloo et al., "Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: No long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group", MED PED ONC, 35(1), 2000, pp. 13-19
24. Matsushita, T; Okamato, M; Toyama, J; Kodama, I; Ito, S; Fukutomi, T; Suzuki, S; Itoh, M
    Adriamycin causes dual inotropic effects through complex modulation of myocardial Ca2+ handling
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    
    T. Matsushita et al., "Adriamycin causes dual inotropic effects through complex modulation of myocardial Ca2+ handling", JPN CIRC J, 64(1), 2000, pp. 65-71
25. Olson, RD; Li, XD; Palade, P; Shadle, SE; Mushlin, PS; Gambliel, HA; Fill, M; Boucek, RJ; Cusack, BJ
    Sarcoplasmic reticulum calcium release is stimulated and inhibited by daunorubicin and daunorubicinol
    TOXICOLOGY AND APPLIED PHARMACOLOGY
    
    R.D. Olson et al., "Sarcoplasmic reticulum calcium release is stimulated and inhibited by daunorubicin and daunorubicinol", TOX APPL PH, 169(2), 2000, pp. 168-176
26. Burke, BE; Gambliel, H; Olson, RD; Baur, FK; Cusack, BJ
    Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat
    BRITISH JOURNAL OF PHARMACOLOGY
    
    B.E. Burke et al., "Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat", BR J PHARM, 131(1), 2000, pp. 1-4
27. Erselcan, T; Kairemo, KJA; Wiklund, TA; Hernberg, M; Blomqvist, CP; Tenhunen, M; Bergh, J; Joensuu, H
    Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer
    BRITISH JOURNAL OF CANCER
    
    T. Erselcan et al., "Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer", BR J CANC, 82(4), 2000, pp. 777-781
28. Okumura, H; Iuchi, K; Yoshida, T; Nakamura, S; Takeshima, M; Takamatsu, H; Ikeno, A; Usuda, K; Ishikawa, T; Ohtake, S; Matsuda, T
    Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity
    ACTA HAEMATOLOGICA
    
    H. Okumura et al., "Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity", ACT HAEMAT, 104(4), 2000, pp. 158-163
29. Tjeerdsma, G; Meinardi, MT; van der Graaf, WTA; van den Berg, MP; Mulder, NH; Crijns, HJGM; de Vries, EGE; van Veldhuisen, DJ
    Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables
    HEART
    
    G. Tjeerdsma et al., "Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables", HEART, 81(4), 1999, pp. 419-423
30. Dell'Acqua, G; Polishchuck, R; Fallon, JT; Gordon, JW
    Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain human multiple drug resistance 1 fusion gene
    HUMAN GENE THERAPY
    
    G. Dell'Acqua et al., "Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain human multiple drug resistance 1 fusion gene", HUM GENE TH, 10(8), 1999, pp. 1269-1279
31. Gennari, A; Salvadori, B; Donati, S; Bengala, C; Orlandini, C; Danesi, R; Del Tacca, M; Bruzzi, P; Conte, PF
    Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors
    JOURNAL OF CLINICAL ONCOLOGY
    
    A. Gennari et al., "Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors", J CL ONCOL, 17(11), 1999, pp. 3596-3602
32. Bu'Lock, FA; Mott, MG; Oakhill, A; Martin, RP
    Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: A prospective study
    PEDIATRIC CARDIOLOGY
    
    F.A. Bu'Lock et al., "Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: A prospective study", PEDIAT CARD, 20(4), 1999, pp. 252-263
33. Hoekman, K; van der Vijgh, WJF; Vermorken, JB
    Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer
    DRUGS
    
    K. Hoekman et al., "Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer", DRUGS, 57(2), 1999, pp. 133-155
34. Sawyer, DB; Fukazawa, R; Arstall, MA; Kelly, RA
    Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane
    CIRCULATION RESEARCH
    
    D.B. Sawyer et al., "Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane", CIRCUL RES, 84(3), 1999, pp. 257-265
35. Papadopoulou, LC; Theophilidis, G; Thomopoulos, GN; Tsiftsoglou, AS
    Structural and functional impairment of mitochondria in adriamycin-inducedcardiomyopathy in mice: Suppression of cytochrome c oxidase II gene expression
    BIOCHEMICAL PHARMACOLOGY
    
    L.C. Papadopoulou et al., "Structural and functional impairment of mitochondria in adriamycin-inducedcardiomyopathy in mice: Suppression of cytochrome c oxidase II gene expression", BIOCH PHARM, 57(5), 1999, pp. 481-489
36. Suzuki, J; Yanagisawa, A; Shigeyama, T; Tsubota, J; Yasumura, T; Shimoyama, K; Ishikawa, K
    Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography
    ANGIOLOGY
    
    J. Suzuki et al., "Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography", ANGIOLOGY, 50(1), 1999, pp. 37-45
37. Kleinhans, E
    Guidelines for equilibrium radionuclide ventriculography
    NUKLEARMEDIZIN
    
    E. Kleinhans, "Guidelines for equilibrium radionuclide ventriculography", NUKLEARMED, 38(6A), 1999, pp. 230-232
38. STEINHERZ LJ; WEXLER LH
    THE PREVENTION OF ANTHRACYCLINE CARDIOMYOPATHY
    Progress in pediatric cardiology
    
    L.J. Steinherz e L.H. Wexler, "THE PREVENTION OF ANTHRACYCLINE CARDIOMYOPATHY", Progress in pediatric cardiology, 8(3), 1998, pp. 97-108
39. HOGARTY AN; SILBER JH; PARIDON SM
    CARDIOPULMONARY EXERCISE TESTING IN EVALUATION OF THE FUNCTIONAL-CAPACITY OF SURVIVORS OF CHILDHOOD-CANCER
    Progress in pediatric cardiology
    
    A.N. Hogarty et al., "CARDIOPULMONARY EXERCISE TESTING IN EVALUATION OF THE FUNCTIONAL-CAPACITY OF SURVIVORS OF CHILDHOOD-CANCER", Progress in pediatric cardiology, 8(3), 1998, pp. 109-119
40. Badary, OA
    Taurine attenuates Fanconi syndrome induced by ifosfamide without compromising its antitumor activity
    ONCOLOGY RESEARCH
    
    O.A. Badary, "Taurine attenuates Fanconi syndrome induced by ifosfamide without compromising its antitumor activity", ONCOL RES, 10(7), 1998, pp. 355-360
41. Bengel, FM; Schwaiger, M
    Nuclear medicine studies of the heart
    EUROPEAN RADIOLOGY
    
    F.M. Bengel e M. Schwaiger, "Nuclear medicine studies of the heart", EUR RADIOL, 8(9), 1998, pp. 1698-1706
42. HASINOFF BB; HELLMANN K; HERMAN EH; FERRANS VJ
    CHEMICAL, BIOLOGICAL AND CLINICAL ASPECTS OF DEXRAZOXANE AND OTHER BISDIOXOPIPERAZINES
    Current medicinal chemistry
    
    B.B. Hasinoff et al., "CHEMICAL, BIOLOGICAL AND CLINICAL ASPECTS OF DEXRAZOXANE AND OTHER BISDIOXOPIPERAZINES", Current medicinal chemistry, 5(1), 1998, pp. 1-28
43. GREEN M
    ANTHRACYCLINE CARDIOTOXICITY, NO LONGER AN ISSUE
    Annals of oncology
    
    M. Green, "ANTHRACYCLINE CARDIOTOXICITY, NO LONGER AN ISSUE", Annals of oncology, 9(7), 1998, pp. 691-693
44. LOPEZ M; VICI P; DILAURO L; CONTI F; PAOLETTI G; FERRAIRONI A; SCIUTO R; GIANNARELLI D; MAINI CL
    RANDOMIZED PROSPECTIVE CLINICAL-TRIAL OF HIGH-DOSE EPIRUBICIN AND DEXRAZOXANE IN PATIENTS WITH ADVANCED BREAST-CANCER AND SOFT-TISSUE SARCOMAS
    Journal of clinical oncology
    
    M. Lopez et al., "RANDOMIZED PROSPECTIVE CLINICAL-TRIAL OF HIGH-DOSE EPIRUBICIN AND DEXRAZOXANE IN PATIENTS WITH ADVANCED BREAST-CANCER AND SOFT-TISSUE SARCOMAS", Journal of clinical oncology, 16(1), 1998, pp. 86-92
45. EWER MS; JAFFE N; RIED H; ZIETZ HA; BENJAMIN RS
    DOXORUBICIN CARDIOTOXICITY IN CHILDREN - COMPARISON OF A CONSECUTIVE DIVIDED DAILY DOSE ADMINISTRATION SCHEDULE WITH SINGLE-DOSE (RAPID) INFUSION ADMINISTRATION
    Medical and pediatric oncology
    
    M.S. Ewer et al., "DOXORUBICIN CARDIOTOXICITY IN CHILDREN - COMPARISON OF A CONSECUTIVE DIVIDED DAILY DOSE ADMINISTRATION SCHEDULE WITH SINGLE-DOSE (RAPID) INFUSION ADMINISTRATION", Medical and pediatric oncology, 31(6), 1998, pp. 512-515
46. HERMAN EH; FERRANS V
    PRECLINICAL ANIMAL-MODELS OF CARDIAC PROTECTION FROM ANTHRACYCLINE-INDUCED CARDIOTOXICITY
    Seminars in oncology
    
    E.H. Herman e V. Ferrans, "PRECLINICAL ANIMAL-MODELS OF CARDIAC PROTECTION FROM ANTHRACYCLINE-INDUCED CARDIOTOXICITY", Seminars in oncology, 25(4), 1998, pp. 15-21
47. SYNOLD TW; TETEF ML; DOROSHOW JH
    ANTINEOPLASTIC ACTIVITY OF CONTINUOUS EXPOSURE TO DEXRAZOXANE - POTENTIAL NEW ROLE AS A NOVEL TOPOISOMERASE-II INHIBITOR
    Seminars in oncology
    
    T.W. Synold et al., "ANTINEOPLASTIC ACTIVITY OF CONTINUOUS EXPOSURE TO DEXRAZOXANE - POTENTIAL NEW ROLE AS A NOVEL TOPOISOMERASE-II INHIBITOR", Seminars in oncology, 25(4), 1998, pp. 93-99
48. ELIHU N; ANANDASBAPATHY S; FRISHMAN WH
    CHELATION-THERAPY IN CARDIOVASCULAR-DISEASE - ETHYLENEDIAMINETETRAACETIC ACID, DEFEROXAMINE, AND DEXRAZOXANE
    Journal of clinical pharmacology
    
    N. Elihu et al., "CHELATION-THERAPY IN CARDIOVASCULAR-DISEASE - ETHYLENEDIAMINETETRAACETIC ACID, DEFEROXAMINE, AND DEXRAZOXANE", Journal of clinical pharmacology, 38(2), 1998, pp. 101-105
49. MORISHIMA I; MATSUI H; MUKAWA H; HAYASHI K; TOKI Y; OKUMURA K; ITO T; HAYAKAWA T
    MELATONIN, A PINEAL HORMONE WITH ANTIOXIDANT PROPERTY, PROTECTS AGAINST ADRIAMYCIN CARDIOMYOPATHY IN RATS
    Life sciences (1973)
    
    I. Morishima et al., "MELATONIN, A PINEAL HORMONE WITH ANTIOXIDANT PROPERTY, PROTECTS AGAINST ADRIAMYCIN CARDIOMYOPATHY IN RATS", Life sciences (1973), 63(7), 1998, pp. 511-521
50. KAPELKO VI; KHATKEVICH AN; TSYPLENKOVA VG; BESKROVNOVA NN
    INITIAL ALTERATIONS OF MYOCARDIAL-FUNCTION AND ULTRASTRUCTURE CAUSED BY LOW-DOSES OF ADRIAMYCIN
    Kardiologia
    
    V.I. Kapelko et al., "INITIAL ALTERATIONS OF MYOCARDIAL-FUNCTION AND ULTRASTRUCTURE CAUSED BY LOW-DOSES OF ADRIAMYCIN", Kardiologia, 38(4), 1998, pp. 24-29
51. Vatutin, NT; Kalinkina, NV
    Cardiac damage by cytostatics
    KARDIOLOGIYA
    
    N.T. Vatutin e N.V. Kalinkina, "Cardiac damage by cytostatics", KARDIOLOGIY, 38(11), 1998, pp. 53-57
52. TORTI SV; AKIMOTO H; LIN K; BILLINGHAM ME; TORTI FM
    SELECTIVE-INHIBITION OF MUSCLE GENE-EXPRESSION BY OXIDATIVE STRESS INCARDIAC-CELLS
    Journal of Molecular and Cellular Cardiology
    
    S.V. Torti et al., "SELECTIVE-INHIBITION OF MUSCLE GENE-EXPRESSION BY OXIDATIVE STRESS INCARDIAC-CELLS", Journal of Molecular and Cellular Cardiology, 30(6), 1998, pp. 1173-1180
53. WISEMAN LR; SPENCER CM
    DEXRAZOXANE - A REVIEW OF ITS USE AS A CARDIOPROTECTIVE AGENT IN PATIENTS RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY
    Drugs
    
    L.R. Wiseman e C.M. Spencer, "DEXRAZOXANE - A REVIEW OF ITS USE AS A CARDIOPROTECTIVE AGENT IN PATIENTS RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY", Drugs, 56(3), 1998, pp. 385-403
54. SCHWARZ ER; POLLICK C; DOW J; PATTERSON M; BIRNBAUM Y; KLONER RA
    A SMALL ANIMAL-MODEL OF NONISCHEMIC CARDIOMYOPATHY AND ITS EVALUATIONBY TRANSTHORACIC ECHOCARDIOGRAPHY
    Cardiovascular Research
    
    E.R. Schwarz et al., "A SMALL ANIMAL-MODEL OF NONISCHEMIC CARDIOMYOPATHY AND ITS EVALUATIONBY TRANSTHORACIC ECHOCARDIOGRAPHY", Cardiovascular Research, 39(1), 1998, pp. 216-223
55. ROSING H; VANGIJN R; HUININK WWT; BEIJNEN JH
    HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE CARDIOPROTECTIVE AGENT DEXRAZOXANE IN HUMAN PLASMA AND URINE
    Journal of liquid chromatography & related technologies
    
    H. Rosing et al., "HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE CARDIOPROTECTIVE AGENT DEXRAZOXANE IN HUMAN PLASMA AND URINE", Journal of liquid chromatography & related technologies, 20(4), 1997, pp. 583-601
56. SCHAADT B; KELBAEK H
    AGE AND LEFT-VENTRICULAR EJECTION FRACTION IDENTIFY PATIENTS WITH ADVANCED BREAST-CANCER AT HIGH-RISK FOR DEVELOPMENT OF EPIRUBICIN-INDUCEDHEART-FAILURE
    Journal of nuclear cardiology
    
    B. Schaadt e H. Kelbaek, "AGE AND LEFT-VENTRICULAR EJECTION FRACTION IDENTIFY PATIENTS WITH ADVANCED BREAST-CANCER AT HIGH-RISK FOR DEVELOPMENT OF EPIRUBICIN-INDUCEDHEART-FAILURE", Journal of nuclear cardiology, 4(6), 1997, pp. 494-501
57. MAINI CL; SCIUTO R; FERRAIRONI A; VICI P; TOFANI A; FESTA A; CONTI F; LOPEZ M
    CLINICAL RELEVANCE OF RADIONUCLIDE ANGIOGRAPHY AND ANTIMYOSIN IMMUNOSCINTIGRAPHY FOR RISK ASSESSMENT IN EPIRUBICIN CARDIOTOXICITY
    Journal of nuclear cardiology
    
    C.L. Maini et al., "CLINICAL RELEVANCE OF RADIONUCLIDE ANGIOGRAPHY AND ANTIMYOSIN IMMUNOSCINTIGRAPHY FOR RISK ASSESSMENT IN EPIRUBICIN CARDIOTOXICITY", Journal of nuclear cardiology, 4(6), 1997, pp. 502-508
58. HERMAN EH; FERRANS VJ
    ANIMAL-MODELS OF ANTHRACYCLINE CARDIOTOXICITY - BASIC MECHANISMS AND CARDIOPROTECTIVE ACTIVITY
    Progress in pediatric cardiology
    
    E.H. Herman e V.J. Ferrans, "ANIMAL-MODELS OF ANTHRACYCLINE CARDIOTOXICITY - BASIC MECHANISMS AND CARDIOPROTECTIVE ACTIVITY", Progress in pediatric cardiology, 8(2), 1997, pp. 49-58
59. BOUCEK RJ
    MECHANISMS FOR ANTHRACYCLINE-INDUCED CARDIOMYOPATHY - CLINICAL AND LABORATORY CORRELATIONS
    Progress in pediatric cardiology
    
    R.J. Boucek, "MECHANISMS FOR ANTHRACYCLINE-INDUCED CARDIOMYOPATHY - CLINICAL AND LABORATORY CORRELATIONS", Progress in pediatric cardiology, 8(2), 1997, pp. 59-70
60. EKSBORG S; BJORKHOLM M; HAST R; FAGERLUND E
    PLASMA PHARMACOKINETICS OF IDARUBICIN AND ITS 13-DIHYDRO METABOLITE -A COMPARISON OF BOLUS VERSUS 2 H INFUSION DURING A 3 DAY COURSE
    Anti-cancer drugs
    
    S. Eksborg et al., "PLASMA PHARMACOKINETICS OF IDARUBICIN AND ITS 13-DIHYDRO METABOLITE -A COMPARISON OF BOLUS VERSUS 2 H INFUSION DURING A 3 DAY COURSE", Anti-cancer drugs, 8(1), 1997, pp. 42-47
61. PROPPER D; MASER E
    CARBONYL REDUCTION OF DAUNORUBICIN IN RABBIT LIVER AND HEART
    Pharmacology & toxicology
    
    D. Propper e E. Maser, "CARBONYL REDUCTION OF DAUNORUBICIN IN RABBIT LIVER AND HEART", Pharmacology & toxicology, 80(5), 1997, pp. 240-245
62. SINGAL PK; ILISKOVIC N; LI TM; KUMAR D
    ADRIAMYCIN CARDIOMYOPATHY - PATHOPHYSIOLOGY AND PREVENTION
    The FASEB journal
    
    P.K. Singal et al., "ADRIAMYCIN CARDIOMYOPATHY - PATHOPHYSIOLOGY AND PREVENTION", The FASEB journal, 11(12), 1997, pp. 931-936
63. HERMAN EH; ZHANG J; HASINOFF BB; CHADWICK DP; CLARK JR; FERRANS VJ
    COMPARISON OF THE PROTECTIVE EFFECTS AGAINST CHRONIC DOXORUBICIN CARDIOTOXICITY AND THE RATES OF IRON(III) DISPLACEMENT-REACTIONS OF ICRF-187 AND OTHER BISDIKETOPIPERAZINES
    Cancer chemotherapy and pharmacology
    
    E.H. Herman et al., "COMPARISON OF THE PROTECTIVE EFFECTS AGAINST CHRONIC DOXORUBICIN CARDIOTOXICITY AND THE RATES OF IRON(III) DISPLACEMENT-REACTIONS OF ICRF-187 AND OTHER BISDIKETOPIPERAZINES", Cancer chemotherapy and pharmacology, 40(5), 1997, pp. 400-408
64. CUSACK BJ; YOUNG SP; VESTAL RE; OLSON RD
    AGE-RELATED PHARMACOKINETICS OF DAUNORUBICIN AND DAUNORUBICINOL FOLLOWING INTRAVENOUS BOLUS DAUNORUBICIN ADMINISTRATION IN THE RAT
    Cancer chemotherapy and pharmacology
    
    B.J. Cusack et al., "AGE-RELATED PHARMACOKINETICS OF DAUNORUBICIN AND DAUNORUBICINOL FOLLOWING INTRAVENOUS BOLUS DAUNORUBICIN ADMINISTRATION IN THE RAT", Cancer chemotherapy and pharmacology, 39(6), 1997, pp. 505-512
65. WEIJL NI; CLETON FJ; OSANTO S
    FREE-RADICALS AND ANTIOXIDANTS IN CHEMOTHERAPY-INDUCED TOXICITY
    Cancer treatment reviews
    
    N.I. Weijl et al., "FREE-RADICALS AND ANTIOXIDANTS IN CHEMOTHERAPY-INDUCED TOXICITY", Cancer treatment reviews, 23(4), 1997, pp. 209-240
66. SUNG RYT; HUANG GY; SHING MK; OPPENHEIMER SJ; LI CK; LI CK; LAU J; YUEN MP
    ECHOCARDIOGRAPHIC EVALUATION OF CARDIAC-FUNCTION IN PEDIATRIC ONCOLOGY PATIENTS TREATED WITH OR WITHOUT ANTHRACYCLINE
    International journal of cardiology
    
    R.Y.T. Sung et al., "ECHOCARDIOGRAPHIC EVALUATION OF CARDIAC-FUNCTION IN PEDIATRIC ONCOLOGY PATIENTS TREATED WITH OR WITHOUT ANTHRACYCLINE", International journal of cardiology, 60(3), 1997, pp. 239-248
67. MATSUDA A; KIMURA M; ITOKAWA Y
    INFLUENCE OF SELENIUM DEFICIENCY ON THE ACUTE CARDIOTOXICITY OF ADRIAMYCIN IN RATS
    Biological trace element research
    
    A. Matsuda et al., "INFLUENCE OF SELENIUM DEFICIENCY ON THE ACUTE CARDIOTOXICITY OF ADRIAMYCIN IN RATS", Biological trace element research, 57(2), 1997, pp. 157-167
68. PENG NJ; ADVANI R; KOPIWODA S; FISHER G; STRAUSS HW
    CLINICAL DECISION-MAKING BASED ON RADIONUCLIDE DETERMINED EJECTION FRACTION IN ONCOLOGY PATIENTS
    The Journal of nuclear medicine
    
    N.J. Peng et al., "CLINICAL DECISION-MAKING BASED ON RADIONUCLIDE DETERMINED EJECTION FRACTION IN ONCOLOGY PATIENTS", The Journal of nuclear medicine, 38(5), 1997, pp. 702-705
69. WITTRY MD; JUNI JE; ROYAL HD; HELLER GV; PORT SC
    PROCEDURE GUIDELINE FOR EQUILIBRIUM RADIONUCLIDE VENTRICULOGRAPHY
    The Journal of nuclear medicine
    
    M.D. Wittry et al., "PROCEDURE GUIDELINE FOR EQUILIBRIUM RADIONUCLIDE VENTRICULOGRAPHY", The Journal of nuclear medicine, 38(10), 1997, pp. 1658-1661
70. FRISHMAN WH; YEE HCM; KEEFE D; DUTCHER J; SUNG HM; LIU LL; EINZIG AI
    CARDIOVASCULAR TOXICITY WITH CANCER-CHEMOTHERAPY
    Current problems in cancer
    
    W.H. Frishman et al., "CARDIOVASCULAR TOXICITY WITH CANCER-CHEMOTHERAPY", Current problems in cancer, 21(6), 1997, pp. 308-360
71. DEGRAAF H; DOLSMA WV; WILLEMSE PHB; VANDERGRAAF WTA; SLEIJFER DT; DEVRIES EGE; MULDER NH
    CARDIOTOXICITY FROM INTENSIVE CHEMOTHERAPY COMBINED WITH RADIOTHERAPYIN BREAST-CANCER
    British Journal of Cancer
    
    H. Degraaf et al., "CARDIOTOXICITY FROM INTENSIVE CHEMOTHERAPY COMBINED WITH RADIOTHERAPYIN BREAST-CANCER", British Journal of Cancer, 76(7), 1997, pp. 943-945
72. JOHNSON D; PERRAULT H; FOURNIER A; LECLERC JM; BIGRAS JL; DAVIGNON A
    CARDIOVASCULAR-RESPONSES TO DYNAMIC SUBMAXIMAL EXERCISE IN CHILDREN PREVIOUSLY TREATED WITH ANTHRACYCLINE
    The American heart journal
    
    D. Johnson et al., "CARDIOVASCULAR-RESPONSES TO DYNAMIC SUBMAXIMAL EXERCISE IN CHILDREN PREVIOUSLY TREATED WITH ANTHRACYCLINE", The American heart journal, 133(2), 1997, pp. 169-173
73. CUSACK BJ; MUSHLIN PS; JOHNSON CJ; VESTAL RE; OLSON RD
    AGING INCREASES THE CARDIOTOXICITY OF DAUNORUBICIN AND DAUNORUBICINOLIN THE RAT
    The journals of gerontology. Series A, Biological sciences and medical sciences
    
    B.J. Cusack et al., "AGING INCREASES THE CARDIOTOXICITY OF DAUNORUBICIN AND DAUNORUBICINOLIN THE RAT", The journals of gerontology. Series A, Biological sciences and medical sciences, 51(5), 1996, pp. 376-384
74. JOHNSON GL; MOFFETT CB; GEIL JD; GREENWOOD MF; NOONAN JA
    LATE ECHOCARDIOGRAPHIC FINDINGS FOLLOWING CHILDHOOD CHEMOTHERAPY WITHNORMAL SERIAL CARDIAC MONITORING
    Journal of pediatric hematology/oncology
    
    G.L. Johnson et al., "LATE ECHOCARDIOGRAPHIC FINDINGS FOLLOWING CHILDHOOD CHEMOTHERAPY WITHNORMAL SERIAL CARDIAC MONITORING", Journal of pediatric hematology/oncology, 18(1), 1996, pp. 72-75
75. JAIN D; ZARET BL
    MYOCARDITIS - A CLINICAL ENTITY THAT CAN BENEFIT FROM NONINVASIVE IMAGING
    Journal of nuclear cardiology
    
    D. Jain e B.L. Zaret, "MYOCARDITIS - A CLINICAL ENTITY THAT CAN BENEFIT FROM NONINVASIVE IMAGING", Journal of nuclear cardiology, 3(5), 1996, pp. 443-445
76. BOVEN E; DEJONG J; KUIPER CM; BAST A; VANDERVIJGH WJF
    RELATIONSHIP BETWEEN THE TUMOR-TISSUE PHARMACOKINETICS AND THE ANTIPROLIFERATIVE EFFECTS OF ANTHRACYCLINES AND THEIR METABOLITES
    European journal of cancer
    
    E. Boven et al., "RELATIONSHIP BETWEEN THE TUMOR-TISSUE PHARMACOKINETICS AND THE ANTIPROLIFERATIVE EFFECTS OF ANTHRACYCLINES AND THEIR METABOLITES", European journal of cancer, 32A(8), 1996, pp. 1382-1387
77. PIHKALA J; SAARINEN UM; LUNDSTROM U; VIRTANEN K; VIRKOLA K; SIIMES MA; PESONEN E
    MYOCARDIAL-FUNCTION IN CHILDREN AND ADOLESCENTS AFTER THERAPY WITH ANTHRACYCLINES AND CHEST IRRADIATION
    European journal of cancer
    
    J. Pihkala et al., "MYOCARDIAL-FUNCTION IN CHILDREN AND ADOLESCENTS AFTER THERAPY WITH ANTHRACYCLINES AND CHEST IRRADIATION", European journal of cancer, 32A(1), 1996, pp. 97-103
78. MIZUNO Y; HARA T; KAWAOTO H; UEDA K
    ATTENUATION OF CARDIOTOXICITY OF DAUNOMYCIN USING A COMPLEX WITH HEPARIN
    International journal of hematology
    
    Y. Mizuno et al., "ATTENUATION OF CARDIOTOXICITY OF DAUNOMYCIN USING A COMPLEX WITH HEPARIN", International journal of hematology, 63(1), 1996, pp. 25-31
79. NOWAK D; DRZEWOSKI J
    ANTHRACYCLINE-INDUCED OXIDATIVE STRESS - ITS ROLE IN THE DEVELOPMENT OF CARDIAC DAMAGE
    The Cancer journal
    
    D. Nowak e J. Drzewoski, "ANTHRACYCLINE-INDUCED OXIDATIVE STRESS - ITS ROLE IN THE DEVELOPMENT OF CARDIAC DAMAGE", The Cancer journal, 9(6), 1996, pp. 296-303
80. LIPSHULTZ SE
    DEXRAZOXANE FOR PROTECTION AGAINST CARDIOTOXIC EFFECTS OF ANTHRACYCLINES IN CHILDREN
    Journal of clinical oncology
    
    S.E. Lipshultz, "DEXRAZOXANE FOR PROTECTION AGAINST CARDIOTOXIC EFFECTS OF ANTHRACYCLINES IN CHILDREN", Journal of clinical oncology, 14(2), 1996, pp. 328-331
81. COTTIN Y; TOUZERY C; COUDERT B; RICHEBOURG S; COHEN M; TOUBEAU M; LOUIS P; WOLF JE; BRUNOTTE F
    DIASTOLIC OR SYSTOLIC LEFT AND RIGHT-VENTRICULAR IMPAIRMENT AT MODERATE DOSES OF ANTHRACYCLINE - A 1-YEAR FOLLOW-UP-STUDY OF WOMEN
    European journal of nuclear medicine
    
    Y. Cottin et al., "DIASTOLIC OR SYSTOLIC LEFT AND RIGHT-VENTRICULAR IMPAIRMENT AT MODERATE DOSES OF ANTHRACYCLINE - A 1-YEAR FOLLOW-UP-STUDY OF WOMEN", European journal of nuclear medicine, 23(5), 1996, pp. 511-516
82. CARRIO I; ESTORCH M; LOPEZPOUSA A
    ASSESSING ANTHRACYCLINE CARDIOTOXICITY IN THE 1990S
    European journal of nuclear medicine
    
    I. Carrio et al., "ASSESSING ANTHRACYCLINE CARDIOTOXICITY IN THE 1990S", European journal of nuclear medicine, 23(4), 1996, pp. 359-364
83. DELLATORRE P; PODESTA A; PINCIROLI G; IATROPOULOS MJ; MAZUE G
    LONG-LASTING EFFECT OF DEXRAZOXANE AGAINST ANTHRACYCLINE CARDIOTOXICITY IN RATS
    Toxicologic pathology
    
    P. Dellatorre et al., "LONG-LASTING EFFECT OF DEXRAZOXANE AGAINST ANTHRACYCLINE CARDIOTOXICITY IN RATS", Toxicologic pathology, 24(4), 1996, pp. 398-402
84. DAVTYAN TK; GYULKHANDANYAN AV; GAMBAROV SS; AVANESSIAN LA; ALEXANYAN YT
    THE EFFECTS OF ADRIAMYCIN AND ADRIAMYCIN COMPLEXES WITH TRANSITIONAL METALS ON CA2(-DEPENDENT K+ CHANNELS OF HUMAN ERYTHROCYTES())
    Biochimica et biophysica acta. Protein structure and molecular enzymology
    
    T.K. Davtyan et al., "THE EFFECTS OF ADRIAMYCIN AND ADRIAMYCIN COMPLEXES WITH TRANSITIONAL METALS ON CA2(-DEPENDENT K+ CHANNELS OF HUMAN ERYTHROCYTES())", Biochimica et biophysica acta. Protein structure and molecular enzymology, 1297(2), 1996, pp. 182-190
85. FRISHMAN WH; SUNG HM; YEE HCM; LIU LL; EINZIG AI; DUTCHER J; KEEFE D
    CARDIOVASCULAR TOXICITY WITH CANCER-CHEMOTHERAPY - INTRODUCTION
    Current problems in cardiology
    
    W.H. Frishman et al., "CARDIOVASCULAR TOXICITY WITH CANCER-CHEMOTHERAPY - INTRODUCTION", Current problems in cardiology, 21(4), 1996, pp. 233
86. DORR RT
    CYTOPROTECTIVE AGENTS FOR ANTHRACYCLINES
    Seminars in oncology
    
    R.T. Dorr, "CYTOPROTECTIVE AGENTS FOR ANTHRACYCLINES", Seminars in oncology, 23(4), 1996, pp. 23-34
87. POUNA P; BONORONADELE S; GOUVERNEUR G; TARIOSSE L; BESSE P; ROBERT J
    DEVELOPMENT OF THE MODEL OF RAT ISOLATED-PERFUSED HEART FOR THE EVALUATION OF ANTHRACYCLINE CARDIOTOXICITY AND ITS CIRCUMVENTION
    British Journal of Pharmacology
    
    P. Pouna et al., "DEVELOPMENT OF THE MODEL OF RAT ISOLATED-PERFUSED HEART FOR THE EVALUATION OF ANTHRACYCLINE CARDIOTOXICITY AND ITS CIRCUMVENTION", British Journal of Pharmacology, 117(7), 1996, pp. 1593-1599
88. BULOCK FA; MOTT MG; OAKHILL A; MARTIN RP
    EARLY IDENTIFICATION OF ANTHRACYCLINE CARDIOMYOPATHY - POSSIBILITIES AND IMPLICATIONS
    Archives of Disease in Childhood
    
    F.A. Bulock et al., "EARLY IDENTIFICATION OF ANTHRACYCLINE CARDIOMYOPATHY - POSSIBILITIES AND IMPLICATIONS", Archives of Disease in Childhood, 75(5), 1996, pp. 416-422
89. MASSING JL; CAILLOT D; MOUHAT T; SCHLESSER P; SOLARY E
    EARLY DIAGNOSIS OF ANTHRACYCLINE CARDIOTO XICITY - VALUE OF RADIOISOTOPIC METHODS
    Archives des maladies du coeur et des vaisseaux
    
    J.L. Massing et al., "EARLY DIAGNOSIS OF ANTHRACYCLINE CARDIOTO XICITY - VALUE OF RADIOISOTOPIC METHODS", Archives des maladies du coeur et des vaisseaux, 89(1), 1996, pp. 57-62
90. HERSHKO C; PINSON A; LINK G
    PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY BY IRON CHELATION
    Acta haematologica
    
    C. Hershko et al., "PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY BY IRON CHELATION", Acta haematologica, 95(1), 1996, pp. 87-92
91. LICHTMAN SM
    PHYSIOLOGICAL-ASPECTS OF AGING - IMPLICATIONS FOR THE TREATMENT OF CANCER
    Drugs & aging
    
    S.M. Lichtman, "PHYSIOLOGICAL-ASPECTS OF AGING - IMPLICATIONS FOR THE TREATMENT OF CANCER", Drugs & aging, 7(3), 1995, pp. 212-225
92. DHINGRA K; FRYE D; NEWMAN RA; WALTERS R; THERIAULT R; FRASCHINI G; SMITH T; BUZDAR A; HORTOBAGYI GN
    PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF PIRARUBICIN IN COMBINATION WITH 5-FLUOROURACIL AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER
    Clinical cancer research
    
    K. Dhingra et al., "PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF PIRARUBICIN IN COMBINATION WITH 5-FLUOROURACIL AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER", Clinical cancer research, 1(7), 1995, pp. 691-697
93. NARULA J; SOUTHERN JF; DEC GW; PALACIOS IF; NEWELL JB; FALLON JT; STRAUSS HW; KHAW BA; YASUDA T
    ANTIMYOSIN UPTAKE AND MYOFIBRILLARLYSIS IN DILATED CARDIOMYOPATHY
    Journal of nuclear cardiology
    
    J. Narula et al., "ANTIMYOSIN UPTAKE AND MYOFIBRILLARLYSIS IN DILATED CARDIOMYOPATHY", Journal of nuclear cardiology, 2(6), 1995, pp. 470-477
94. CARRIO I; BALLESTER M
    CLINICAL FUTURE OF ANTIMYOSIN IMAGING IN NONCORONARY HEART-DISEASE
    Journal of nuclear cardiology
    
    I. Carrio e M. Ballester, "CLINICAL FUTURE OF ANTIMYOSIN IMAGING IN NONCORONARY HEART-DISEASE", Journal of nuclear cardiology, 2(2), 1995, pp. 155-158
95. MAINI CL; PERRAIRONI A; SCIUTO R; VICI P; TOFANI A; CONTI F; LOPEZ M
    CARDIOTOXICITY OF HIGH-DOSE-RATE EPIRUBICIN EVALUATED BY ANGIOCARDIOSCINTIGRAPHY
    Oncology Reports
    
    C.L. Maini et al., "CARDIOTOXICITY OF HIGH-DOSE-RATE EPIRUBICIN EVALUATED BY ANGIOCARDIOSCINTIGRAPHY", Oncology Reports, 2(3), 1995, pp. 443-446
96. MAZUE G; IATROPOULOS M; IMONDI A; CASTELLINO S; BRUGHERA M; PODESTA A; DELLATORRE P; MONETA D
    ANTHRACYCLINES - A REVIEW OF GENERAL AND SPECIAL TOXICITY STUDIES
    International journal of oncology
    
    G. Mazue et al., "ANTHRACYCLINES - A REVIEW OF GENERAL AND SPECIAL TOXICITY STUDIES", International journal of oncology, 7(4), 1995, pp. 713-726
97. OLMOS RAV; HUININK WWT; TENHOEVE RFA; VANTINTEREN H; BRUNING PF; VANVLIES B; HOEFNAGEL CA
    ASSESSMENT OF ANTHRACYCLINE-RELATED MYOCARDIAL ADRENERGIC DERANGEMENTBY [I-123] METAIODOBENZYLGUANIDINE SCINTIGRAPHY
    European journal of cancer
    
    R.A.V. Olmos et al., "ASSESSMENT OF ANTHRACYCLINE-RELATED MYOCARDIAL ADRENERGIC DERANGEMENTBY [I-123] METAIODOBENZYLGUANIDINE SCINTIGRAPHY", European journal of cancer, 31A(1), 1995, pp. 26-31
98. PEIN F; VASSAL G; SAKIROGLU C; TOURNADE MF; LEMERLE J
    PEDIATRIC FEATURES OF ANTHRACYCLINES CARD IAC TOXICITY AND PRACTICAL IMPLICATIONS FOR PREVENTION
    Archives de pediatrie
    
    F. Pein et al., "PEDIATRIC FEATURES OF ANTHRACYCLINES CARD IAC TOXICITY AND PRACTICAL IMPLICATIONS FOR PREVENTION", Archives de pediatrie, 2(10), 1995, pp. 988-999
99. HOUSTON SH; SINNOTT JT
    MANAGEMENT OF THE TRANSPLANT RECIPIENT WITH PULMONARY INFECTION
    Infectious disease clinics of North America
    
    S.H. Houston e J.T. Sinnott, "MANAGEMENT OF THE TRANSPLANT RECIPIENT WITH PULMONARY INFECTION", Infectious disease clinics of North America, 9(4), 1995, pp. 965
100. ANDERLINI P; BENJAMIN RS; WONG FC; KANTARJIAN HM; ANDREEFF M; KORNBLAU SM; OBRIEN S; MACKAY B; EWER MS; PIERCE SA; ESTEY EH
     IDARUBICIN CARDIOTOXICITY - A RETROSPECTIVE STUDY IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASIA
     Journal of clinical oncology
     
     P. Anderlini et al., "IDARUBICIN CARDIOTOXICITY - A RETROSPECTIVE STUDY IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASIA", Journal of clinical oncology, 13(11), 1995, pp. 2827-2834